Skip to main content

CJ-033466









CJ-033466


From Wikipedia, the free encyclopedia

Jump to navigation
Jump to search

































CJ-033466
CJ-033466.svg
Identifiers

PubChem CID
  • 10429706
ChemSpider
  • 8605134
Chemical and physical data
Formula
C19H28ClN5O
Molar mass 377.910 g/mol
3D model (JSmol)
  • Interactive image

.mw-parser-output .nobold{font-weight:normal}
  (verify)

CJ-033466 is a drug which acts as a potent and selective 5-HT4 serotonin receptor partial agonist. In animal tests it stimulated gastrointestinal motility with 30 times the potency of cisapride, and with lower affinity for the hERG channel.[1][2][3]



See also[edit]


  • Imidazopyridine


References[edit]





  1. ^ Mikami T, Ochi Y, Suzuki K, Saito T, Sugie Y, Sakakibara M (April 2008). "5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs". The Journal of Pharmacology and Experimental Therapeutics. 325 (1): 190–9. doi:10.1124/jpet.107.133850. PMID 18198343..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output q{quotes:"""""""'""'"}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}


  2. ^ Toga T, Kohmura Y, Kawatsu R (October 2007). "The 5-HT(4) agonists cisapride, mosapride, and CJ-033466, a Novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities". Journal of Pharmacological Sciences. 105 (2): 207–10. doi:10.1254/jphs.sc0070243. PMID 17928736.


  3. ^ Tsuchida Y, Hatao F, Fujisawa M, Murata T, Kaminishi M, Seto Y, Hori M, Ozaki H (May 2011). "Neuronal stimulation with 5-hydroxytryptamine 4 receptor induces anti-inflammatory actions via α7nACh receptors on muscularis macrophages associated with postoperative ileus". Gut. 60 (5): 638–47. doi:10.1136/gut.2010.227546. PMC 3071096. PMID 21115544.















Retrieved from "https://en.wikipedia.org/w/index.php?title=CJ-033466&oldid=722521843"





Navigation menu

























(window.RLQ=window.RLQ||).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.728","walltime":"0.928","ppvisitednodes":{"value":3999,"limit":1000000},"ppgeneratednodes":{"value":0,"limit":1500000},"postexpandincludesize":{"value":300207,"limit":2097152},"templateargumentsize":{"value":2794,"limit":2097152},"expansiondepth":{"value":14,"limit":40},"expensivefunctioncount":{"value":3,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":10424,"limit":5000000},"entityaccesscount":{"value":3,"limit":400},"timingprofile":["100.00% 607.410 1 -total"," 64.84% 393.826 1 Template:Drugbox"," 43.07% 261.619 1 Template:Infobox"," 20.51% 124.563 20 Template:Navbox"," 19.93% 121.081 1 Template:Reflist"," 17.45% 105.972 3 Template:Cite_journal"," 11.05% 67.130 16 Template:Unbulleted_list"," 8.52% 51.755 1 Template:Serotonergics"," 5.92% 35.985 1 Template:Infobox_drug/chemical_formula"," 4.17% 25.322 1 Template:Infobox_drug/maintenance_categories"]},"scribunto":{"limitreport-timeusage":{"value":"0.221","limit":"10.000"},"limitreport-memusage":{"value":4274380,"limit":52428800}},"cachereport":{"origin":"mw1255","timestamp":"20181215210801","ttl":1900800,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":104,"wgHostname":"mw1274"});});

Popular posts from this blog

Full-time equivalent

さくらももこ

13 indicted, 8 arrested in Calif. drug cartel investigation